Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Learn how Volatility Dividend Aristocrats Etf behaves across cycles and what it means for risk budgeting and position sizing in volatile markets.
20,128 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A multi trillion funding surge is intensifying the race to dominate AI, as tech giants and investors flood capital in...
The Justice Department filed a federal civil rights lawsuit against Harvard, alleging leadership failed to curb antis...
DeFi is at a crossroads: grow or endure risk. Experts propose a defended capital metric to measure true resilience be...
Berkshire Hathaway sits on a massive stock portfolio and a mountain of cash. As leadership quietly shifts, investors ...
Lenders posted healthier profits per loan in Q3 2025, but declined loans still drain resources. A new declined loan a...
The European Union and Mercosur clinched a landmark free-trade agreement after 25 years of negotiations, linking 700 ...
A high-profile kidnapping tied to crypto ransom ends in an arrest abroad, underscoring risks for the crypto ecosystem...
The mortgage industry built sales infrastructure over decades. Now, as tech automates the process, it is shifting tow...
A new anti-spam proposal at the heart of Bitcoin’s governance debate has sparked a power struggle, with analysts ques...
Solana sits at a pivotal juncture in 2026, with traders weighing a rising wedge against thinning volume and a stubbor...
Arm is venturing into silicon design after decades as a licensing powerhouse. This bold shift could impact AI data ce...